| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-16 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-13 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.31 | 9e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-11 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |